During the past decade, DBC Research conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 9 clinical trials were completed, i.e. on average, 52.9% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 6 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DBC Research" #1 sponsor was "Pfizer" with 6 trials, followed by "Shire" with 5 trials sponsored, "Pulmotect, Inc." with 2 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored and "Ellodi Pharmaceuticals, LP" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DBC Research" #1 collaborator was "United States Department of Defense" with 2 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "DBC Research" are "COVID-19" (3 trials), "Cardiovascular Disease" (3 trials), "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials) and "Influenza, Human" (2 trials). Many other conditions were trialed in "DBC Research" in a lesser frequency.

Most popular intervention types in "DBC Research" are "Drug" (14 trials), "Biological" (5 trials), "Other" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Ontamalimab" (4 trials), "PUL-042 Inhalation Solution" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "25 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "DBC Research" are 20 trials for "All" genders.

Currently, there are NaN active trials in "DBC Research". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in DBC Research, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in DBC Research, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".